en

PRODUCT DETAIL

Jaypirca 50 mg filmom obalené tablety

Code 4978E
MA number EU/1/23/1738/003
Product Form: tbl flm 84x50 mg (blis.PVC/PCTFE/Al)
MA Status: Ex - Conditional centralised marketing authorisation
Type of procedure: EU
MAH, country: Eli Lilly Nederland B.V., Netherland
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EL Bruton`s tyrosine kinase (BTK) inhibitors
L01EL05 Pirtobrutinib
Shelf life: 36
Container: blister PVC/PCTFE/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 30.10.2023
Validity: 31.10.2025
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 07.05.2025
eu-flag.png sk-flag.png